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Abstract
Background: Notch signalling plays a central role in the mechanisms regulating neuronal differentiation in the vertebrate
nervous system. The transcriptional repressors encoded by Hes genes are the main effectors of this pathway, acting in neural
progenitors during the lateral inhibition process to repress proneural genes and inhibit differentiation. However, Hes6 genes
seem to behave differently: they are expressed in differentiating neurons and facilitate the activity of proneural genes in
promoting neurogenesis.Still,themolecularmechanismsunderlyingthisunique function ofHes6genes are not yet understood.
Methodology/Principal Findings: Here, we identify two subgroups of Hes6 genes that seem conserved in most vertebrate
species and characterize a novel Hes6 gene in chicken: cHes6-1. The embryonic expression pattern of cHes6-1 suggests roles
for this gene in the formation of the pancreas, nervous system and in the generation of body asymmetry. We show that
cHes6-1 is negatively regulated by Notch signalling in the developing embryonic spinal cord and in pancreatic progenitors,
but requires Notch for the observed asymmetric expression at the lateral mesoderm. Functional studies by ectopic
expression in the chick embryonic neural tube revealed that cHES6-1 up-regulates the expression of cDelta1 and cHes5
genes, in contrast with overexpression of cHES6-2, which represses the same genes. We show that this activity of cHES6-2 is
dependent on its capacity to bind DNA and repress transcription, while cHES6-1 seems to function by sequestering other
HES proteins and inhibit their activity as transcriptional repressors.
Conclusions/Significance: Our results indicate that the two chick HES6 proteins act at different phases of neuronal
differentiation, contributing to the progression of neurogenesis by different mechanisms: while cHES6-2 represses the
transcription of Hes genes, cHES6-1 acts later, sequestering HES proteins. Together, the two cHES6 proteins progressively
shut down the Notch-mediated progenitor program and ensure that neuronal differentiation can proceed.
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Introduction
The vertebrate central nervous system derives from an
embryonic structure called the neural tube. In this tissue, dividing
neural progenitors reside in the ventricular zone (VZ), near the
lumen of the tube. Progenitor cells have attachments at the apical
and basal sides of the neuroepithelium and their nuclei show a
characteristic interkinetic nuclear movement, with mitotic nuclei
being always located apically ([1]; reviewed in [2]). After division,
neuroepithelial cells either remain as progenitors in the VZ or
commit to differentiation, moving out of the VZ to a more basal
region called the mantle layer, where neuronal differentiation
proceeds. During neurogenesis, there is a balance between
progenitor proliferation and differentiation, maintaining a resident
population of progenitors to ensure that neurogenesis can progress
and produce the correct number (and types) of neuronal cells
during development. This balance is regulated by Notch signalling
(reviewed in [3]), a pathway that is based on cell-cell interactions:
after the contact between a membrane bound ligand (Delta or
Serrate) of one cell and a membrane bound Notch receptor on
another cell, the receptor suffers a proteolytic cleavage catalyzed
by c-secretase, releasing the intracellular domain (NICD) from the
membrane. The NICD protein then translocates to the nucleus
where it binds CSL (CBF1, Suppressor of Hairless, Lag-1) and
Mastermind (MAM), turning CSL from a transcriptional repressor
into a transcriptional activator. The tripartite NICD/CSL/MAM
complex activates the transcription of several downstream targets,
the best characterized being the Hes genes (Drosophila Hairy and
Enhancer of Split homologues), which encode basic helix-loop-helix
(bHLH) transcriptional repressors (reviewed in [4]). HES proteins
contain a basic region for DNA binding and a helix-loop-helix
region for homo- or heterodimerization, as well as an Orange
domain involved in protein-protein interactions specificity and a
C-terminal tetrapeptide (WRPW) for interactions with the co-
repressor Groucho/TLE (reviewed in [5,6]). HES proteins
normally act as dimers, bind to specific sequences named N- or
E- boxes in target promoters, recruit the co-repressor TLE and
repress the transcription of target genes. Known targets include
the proneural genes, which are involved in promoting neuronal
differentiation. During neurogenesis, newborn neurons express
high levels of proneural factors, which promote expression of the
ligands Delta or Serrate. These ligands signal to neighbouring
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HES protein expression and a block on the activity of proneural
genes, thereby preventing progenitor differentiation, in a process
called lateral inhibition (reviewed in [4,6,7]).
Although vertebrate HES proteins usually function as Notch
effectors to inhibit neuronal differentiation in the developing
nervous system, studies in mouse, Xenopus and in vitro have shown
that one particular HES protein, HES6, acts differently,
promoting neurogenesis when ectopically expressed [8–12]. This
seems to be due to HES6’s ability to inhibit the activity of anti-
neurogenic HES proteins, leading to an increase on the expression
and activity of proneural proteins, such as Neurogenins, in cells
where they are already expressed [8–11,13]. In turn, Neurogenins
increase HES6 levels in a positive feedback-loop [8], thus
reinforcing the activity of the proneural differentiation cascade.
Another proneural protein, ASCL1, was shown to bind to E boxes
in the mHes6 promoter [14,15], and might also be a positive
regulator of mHES6 during neurogenesis.
Multiple mechanisms have been shown to contribute to the
inhibitory activity of HES6 on anti-neurogenic HES factors, but
these do not seem to involve a DNA-binding dependent transcrip-
tional activityofHES6.Instead,themouse HES6proteinwasshown
to form heterodimers with HES1 and prevent recruitment of the
transcriptional co-repressor TLE, necessary for HES1 repressive
activity [9,10,13]. In addition, binding of HES6 to HES1 seems to
cause proteolytic degradation of the heterodimer, mediated by
phosphorylation of a specific serine residue in HES6 [10,13].
In the chick embryo, two Hes6 genes are expressed and the
product of one of them, cHES6-2, has been shown to cooperate with
the proneural proteins to promote neuronal differentiation [16],
although the underlying molecular mechanisms are not known. The
function of the second HES6 protein, cHES6-1 [16], is also still
unknown. In this study, we investigated the expression and function
of cHES6-1 and show that it is expressed in all three germ layers of
the chick embryo, particularly in the nervous system, heart, and
pancreas. cHes6-1 is asymmetrically expressed in the mesoderm
lateral to the primitive streak, suggesting a role for this gene in the
formation of body asymmetry. cHes6-1 expression is negatively
regulated by Notch signalling in the embryonic spinal cord and
pancreas. However, in the mesoderm lateral to the primitive streak,
cHes6-1 expression requires Notch activity, suggesting different
regulation of this gene in distinct tissues. In the embryonic spinal
cord, the two chick Hes6 genes are transiently expressed in
differentiating neurons and function in the genetic cascade
regulating neuronal differentiation, acting by different mechanisms.
While cHES6-2 functions as a transcriptional repressor, cHES6-1
functions by sequestering and inhibiting other HES proteins.
Together, the two chick HES6 proteins regulate neurogenesis by
contributing to releasedifferentiating neurons from Notch signalling.
Results
HES6 proteins are divided in two subgroups
We have previously reported the existence of two Hes6-like genes
in the chick genome, cHes6-1 and cHes6-2 [16]. A more detailed
analysis of available genomic data reveals that the two genes are
linked in chromosome 9, close to the Period2 gene (Ensemble ref.
ENSGALG00000005521) (Fig. 1A). We found that two different
Hes6 genes are equally present in the genomes of zebrafish, medaka
and Xenopus, while only one Hes6 gene is present in mouse and
humans. Alignment of the various HES6 proteins reveals that they
can be classified into two distinct subgroups, with unique structural
features (Fig. 1B). These include a particular serine residue
specifically present in all HES6-1 proteins (position 175 of cHES6-
1), reported to be important for mHES6-dependent induction of
neurogenesis [10], and a lysine residue present in the bHLH domain
of all HES6-2 proteins (position 59 of cHES6-2), suggested to be
essential for transcriptional repression ability of HES proteins [17].
However, the major structural difference between the two subgroups
of HES6 proteins concerns the shorter loop in the bHLH domain of
the HES6-1 proteins, when compared with HES6-2 subgroup.
cHes6-1 expression pattern
The expression pattern of cHes6-1 throughout chick embryonic
development was determined by in situ hybridization on whole-
mount embryos and cryostat sections. At HH4 (Hamburger and
Hamilton stages [18]), cHes6-1 is expressed in the epiblast and
Hensen’s node (Fig. 2A). As the node starts regressing at HH5,
expression of cHes6-1 is also detected in the emerging head process
(Fig. 2B). During gastrulation, cHes6-1 is always expressed around
Hensen’s node and in the forming notochord. Other sites of cHes6-1
expression in early embryos (HH5-12) include the neural folds and
neural tube, the cranial placodes, the infundibulum and the
prospective heart (Fig. 2C-Gi,Giii,Giv and data now shown).
Expression can also be detected in the lateral mesoderm flanking
the regressing node in 5 somite embryos, but only in the left side
(arrow in Fig. 2D). This asymmetric expression continues
throughout HH9 and HH10 and finally equalizes in both sides at
HH11 (Fig. 2E-G,Gv,Gvi and data not shown). At 7 somites,
expression of cHes6-1 is also detected in a salt-and-pepper pattern in
the endoderm, in the region between the 3
rd and 5
th somites. This
expression expandsandshiftsmore posteriorlyastheembryogrows:
inembryoswith 18somites,expression extends upto the 13
thsomite
level and spans around 6 somites (Fig. 2F,G,Gii and data not
shown). This expression of cHes6-1 in the endoderm resembles the
location of pancreatic precursors in 1.5-day-old chick embryos, as
determined by fate mapping [19,20] and expression of the
pancreatic markers Nkx6-1,2,3, Nkx2.2 and Pdx1 [21]. Since Notch
signalling has been previously reported to be involved in pancreatic
development [22], we also analysed the expression of other
components of the Notch pathway in this region of the endoderm.
We found that cHes6-2 is the only other Hes gene expressed in the
same region, as we could not detect expression of cHes5-1,c Hes5-2,
cHes5-3,c Hairy1 or cHairy2 (Fig. 2H and data not shown). We also
assessed the expression of Notch ligands and found that only cDelta1
is expressed with a similar spatio-temporal pattern to cHes6-1 in the
endoderm (Fig. 2I and data not shown).
To determine whether cHes6-1 expression in the embryo is under
Notch control, we inhibited Notch signalling in ovo by treating
embryos with a highlyspecificc-secretaseinhibitor(LY411575)[23]
and assessed the effect on cHes6-1 expression. In the absence of
Notch activity, cHes6-1 expression in the lateral mesoderm is
strongly reduced (28/32 treated embryos, Fig. 2L), showing that
cHes6-1 requires Notch signalling to be asymmetrically expressed in
this region of the embryo. In the endoderm, on the contrary,
inhibition of Notch activity leads to an increase in cHes6-1
expression (30/34 treated embryos, Fig. 2M), revealing that Notch
signalling negatively regulates cHes6-1 expression in the prospective
pancreas. This is consistent with a study showing that cHes6-1 is
down-regulated in the developing pancreas of later stage embryos
after overexpression of an active form of the Notch receptor [24].
Together, these results show that cHes6-1 is differently regulated in
different regions of the developing chick embryo.
cHes6-1 is expressed in post-mitotic cells in the outer
ventricular zone of the spinal cord
Analysis by whole-mount in situ hybridization shows that
cHes6-1 is expressed throughout the developing nervous system
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neurogenesis at neural plate stages [25] (Fig. 2). To further
examine the expression of cHes6-1 in the neural tube, we have
performed in situ hybridizations in cryostat sections of E3-E7
embryos. While in E3 embryos, cHes6-1 expression is located
throughout the spinal cord and expressing cells are mostly basal
(Fig. 3A), in E4 embryos it is expressed in cells located at the
border between the VZ and the mantle layer, across the whole
dorso-ventral axis, (Fig. 3B). From E4 to E7, we observe cHes6-1
expression progressively disappearing from the ventral region,
correlating with the completion of neurogenesis in this region
(Fig. 3C).
Figure 1. HES6 subgroups. (A) Location and orientation of the single mouse Hes6 and the two chick Hes6 genes in chromosomes 1 and 9,
respectively. In both genomes, Hes6 genes are present in close proximity to the Period2 gene. (B) Sequence alignments of HES6 proteins from
different species. HES6 protein sequences were obtained in Ensemble or NCBI and have the following accession numbers. Homo sapiens: HES6,
ENSP00000272937. Mus musculus: HES6, ENSMUSP00000084062. Gallus gallus: HES6-2, ENSGALP00000008850. Xenopus tropicalis: HES6-1,
ENSXETP00000013003; HES6-2, NP_001072210. Oryzias latipes: HER13.1, ENSORLP00000020797; HER13.2, ENSORLP00000019320; HER8, EN-
SORLP00000019320. Danio rerio: HER13.1, ENSDARP00000012990; HER13.2 ENSDARP00000021078; HER8.1, ENSDARP00000010206; HER8.2,
ENSDARP00000103093. Accession number of Gallus gallus HES6-1 is unavailable, but can be identified in GenBank (BI393243). Shaded areas
represent regions of homology. The HES6 proteins are divided in two subgroups: HES6-1 and HES6-2. The main protein domains are indicated. Amino
acid residues that were mutated in our experiments are marked with asterisks. h: human; m: mouse; c: chick; x: Xenopus; meda: medaka; zf: zebrafish.
doi:10.1371/journal.pone.0015459.g001
Figure 2. cHes6-1 expression pattern and response to Notch inhibition. (A-G) Expression of cHes6-1 at stages (A) HH4, (B) HH5, (C) HH6, (D)
HH8, (E) HH9 (dorsal view), (F) HH9 (ventral view), (G) HH10. (Gi-Gvi) Sections through the regions marked with the white dashed lines on HH10
embryo in (G). Arrows in (D-F) point to the asymmetric expression of cHes6-1 in the mesoderm lateral to the primitive streak. (H-I) Ventral view of
embryos showing expression of (H) cHes6-2 at HH12 and (I) cDelta1 at HH10 in pancreatic progenitors, identified by arrows. (J-N) Expression of cHes6-
1 in embryos treated with the Notch signalling inhibitor LY411575. Down-regulation of cHes6-1 can be detected in the mesoderm lateral to the
primitive streak (L, dorsal view) and up-regulation of cHes6-1 in pancreatic progenitors (M, ventral view) and neural tube (N, dorsal view), when
compared to control embryos treated with PBS (J, dorsal, and K, ventral view). Arrows in (J-N) point to regions of the embryo where cHes6-1
expression if affected by Notch signalling inhibition. ep: epiblast; h: heart; hf: head fold; hn: Hensen’s node; hp: head process; mlps: mesoderm lateral
to the primitive streak; n: notochord; nf: neural fold; nt: neural tube; p: pancreatic progenitors; sr: sinus rhomboidalis.
doi:10.1371/journal.pone.0015459.g002
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in the neural tube, we treated embryos in ovo with a pulse of
Bromodeoxyuridine (BrdU) to mark cells in S-phase. Following
immunohistochemistry for BrdU and in situ hybridization to detect
cHes6-1 expression, we found that cells expressing cHes6-1 do not
incorporate BrdU (Fig. 3D-Fi), showing that cHes6-1 is expressed
in post-mitotic cells in the developing neural tube. However,
double-labelling with Tuj-1, which marks early born neurons [26],
does not show co-expression of cHes6-1 (Fig. 3G-Ii), indicating that
this gene is expressed transiently during the initial phases of
Figure 3. Expression of cHes6-1 in differentiating cells of the spinal cord. (A-C) Expression of cHes6-1 (red) in spinal cord sections of (A) E3,
(B) E4 and (C) E7 embryos. Nuclei were counterstained with DAPI (blue). (D-Li) cHes6-1 (red) is expressed in post-mitotic cells of spinal cord of E4
embryos, as shown by the absence of BrdU incorporation (30 minute pulse (green)) in these cells (D-Fi). However, cHes6-1-expressing cells are not
fully differentiated, as demonstrated by absence of Tuj-1 co-labelling (green) (G-Ii). By contrast, in cranial ganglia cHes6-1 is expressed in Tuj-1
+
differentiated neurons (J-Li). (Fi), (Ii), (Li) are magnifications of the selected areas in (F), (I), (L), respectively. Arrows identify cells wherec Hes6-1
expression coincides with Tuj-1. drg: dorsal root ganglion; n: notochord; nt: neural tube.
doi:10.1371/journal.pone.0015459.g003
HES6 and Neuronal Differentiation
PLoS ONE | www.plosone.org 5 December 2010 | Volume 5 | Issue 12 | e15459neuronal differentiation in the spinal cord. Nonetheless, a clear co-
localization between cHes6-1 expression and Tuj-1 in dorsal root
ganglia and cranial ganglia is observed (Fig. 3J-Li and data not
shown), revealing a different timing for cHes6-1 expression in
peripheral neurogenesis.
cHes6-1 is part of the neuronal differentiation cascade of
bHLH genes
During vertebrate neurogenesis, a cascade of expression of
proneural and neuronal differentiation genes encoding bHLH
transcriptional regulators, such as Neurogenins, NEUROM and
NEUROD1, regulate consecutive steps of differentiation (reviewed
in [27,28–30]). To relate the expression of cHes6-1 with the
cascade of proneural bHLH expression, we performed double in
situ hybridization with probes for cHes6-1 and various bHLH-
encoding genes. We started with the proneural gene cNeurog1 [31],
which is mainly expressed in the ventral region of the developing
spinal cord, with an additional dorsal stripe (dI2 [32]) (Fig. 4B).
Analysis of in situ data revealed that cells in the VZ have different
levels of cNeurog1 expression and that cells with higher levels of
cNeurog1 are present more basally in the VZ, co-expressing cHes6-1
(Fig. 4A-Ci). We next analysed cNeurog2 [33] expression, which in
the ventral region is very similar to cNeurog1, with higher
expressing cells also located more basally and co-expressing
cHes6-1 (Fig. 4D-Fi). In the dorsal part of the neural tube,
cNeurog2-expressing cells are uniformly located at the basal part of
the VZ and show extensive co-expression of cHes6-1 (Fig. 4D-Fi).
The finding that cHes6-1-expressing cells show the highest levels of
Neurogenin expression is in agreement with previous findings that
show activation of HES6 expression by Neurogenins and
cooperativity between both proteins to promote neuronal
differentiation [8,16].
Subsequently, we compared cHes6-1 expression to that of
cNeuroM, which is expressed in differentiating neurons [34].
Double in situ hybridization shows co-expression of cHes6-1 and
cNeuroM along the dorso-ventral axis, with cells co-expressing both
genes located more apically than cells expressing only cNeuroM
(Fig. 4G-Ii). This suggests that cNeuroM expression persists longer
in differentiating neurons, after cHes6-1 expression is extinguished.
Together, our results point to the following order of expression in
differentiating neurons of the ventral spinal cord: cNeurog1/
cNeurog2 R cNeurog1/cNeurog2/cNeuroM/cHes6-1 R cNeuroM
(Fig. 4P).
We have previously identified a circuitry of cHes5 and cHes6-2
activity during chick neurogenesis, with cHes6-2 functioning as a
regulator of the three cHes5 genes [16]. Therefore, we compared
the expression of cHes6-1 to that of cHes6-2 in these early steps of
neuronal differentiation in the developing spinal cord. We found
that the majority of cHes6-1-expressing cells are located more
basally than cells expressing cHes6-2, although the two cHes6 genes
are co-expressed in some cells (Fig. 4J-Li). This indicates that
expression of cHes6-1 in newborn neurons occurs later than cHes6-
2 expression. In relation to cDelta1, which is reported to be
expressed after cHes6-2 [16], we found that this gene is expressed
in cells located more apically that cHes6-1-expressing cells, again
with co-expression in some cells (Fig. 4M-Oi). Together, these
results suggest the following sequence for the expression of these
three genes in cells entering differentiation and initiating their
migration out of the VZ: cHes6-2 R cDelta1 R cHes6-1 (Fig. 4P).
Regulation of cHes6-1 in the spinal cord
The results described above show that cHes6-1 expression
occurs in cells that have already committed to neuronal
differentiation. Therefore, cHes6-1-expressing cells should not
present Notch activity, which is only present in progenitors to
maintain their neurogenic potential. This is in agreement with
non-overlapping expression domains of cHes6-1 and cNotch1 in the
developing spinal cord (Fig. 5A-Ci). Here, the two genes are
transcribed in cells located in different regions of the neuroepi-
thelium, cNotch1 in apical progenitors at the ventricular zone and
cHes6-1 in differentiating cells located at the border between the
VZ and the mantle layer.
As cHes6-1 is expressed in differentiating neurons, interfering
with neurogenesis should lead to alterations in its pattern of
expression. To assess this, we examined the expression of cHes6-1
in the spinal cord of embryos where neurogenesis is blocked or
accelerated, by manipulating Notch activity in the neuroepithe-
lium. To block neurogenesis by increasing Notch activity, we
electroporated chick embryos with a plasmid encoding a
constitutively active form of the NOTCH1 receptor, NICD.
Analysis of cHes6-1 expression in the spinal cord of these embryos
shows that the number of cells expressing cHes6-1 is reduced when
Notch is ectopically activated and neurogenesis is blocked (Fig. 5D-
Fi). To accelerate neurogenesis by reducing Notch activity, we
electroporated chick embryos with a plasmid encoding a dominant
negative form of CSL (CSLDN). We also reduced Notch activity
by treating embryos in ovo with the c-secretase inhibitor LY411575
[23]. Analysis of cHes6-1 expression in the spinal cord of these
embryos shows that the number of cells expressing cHes6-1 is
increased when neurogenesis is accelerated due to Notch
inactivation (Fig. 2N, 5G-Ii). The correlation of cHes6-1 expression
levels with the rate of neurogenesis confirms that cHes6-1 is
expressed in cells committed to neuronal differentiation, a process
driven by the activity of proneural genes. Given our previous
finding that cHes6-1 and the proneural gene Neurog2 are co-
expressed in various domains of the developing spinal cord
(Fig. 4D-Fi), we next asked whether NEUROG2 can regulate
cHes6-1 expression. To test this, a plasmid encoding NEUROG2
was electroporated into the chick neural tube. Upon NEUROG2
overexpression, we observe a cell-autonomous increase in cHes6-1
expression (Fig. 5J-Li), showing that cHes6-1 is expressed
downstream of proneural genes during the process of neuronal
differentiation in the developing spinal cord.
cHES6-1 and cHES6-2 exert their function through
different molecular mechanisms
Our previous work with cHes6-2 revealed that this gene is active
in differentiating neurons and serves to repress transcription of the
three cHes5 genes encoding Notch effectors [16]. These are
homologues of mouse Hes5, which has been shown to be the major
target and effector of Notch signalling in the developing vertebrate
nervous system [35,36]. Therefore, cHes6-2 repression on the
three chick Hes5 genes helps to relieve differentiating neurons from
Notch activity. Our finding that cHes6-1 is also expressed in
differentiating neurons, starting later than cHes6-2, but still
overlapping with it (Fig. 4J-Li), suggests that cHes6-1 is also part
of the mechanisms acting to cease Notch activity, promoting
neuronal differentiation. To assess if cHes6-1 promotes neuronal
differentiation, we ectopically expressed this gene in the embryonic
chick neuroepithelium and analysed the expression of the early
neuronal marker cDelta1 [37]. Upon cHes6-1 overexpression, we
observe a cell-autonomous up-regulation of cDelta1 (80% of
electroporated embryos, n=44) (Fig. 6A-Ci), indicating that
cHES6-1 promotes neuronal differentiation in a cell-autonomous
fashion. This contrasts with the activity of cHES6-2, which
represses cDelta1 expression [16]. cHES6-2 is also a repressor of
the cHes5 genes (Fig. 6I-J, 7B and [16]) and we observed that
cHes6-1 overexpression leads also to a contrasting phenotype,
HES6 and Neuronal Differentiation
PLoS ONE | www.plosone.org 6 December 2010 | Volume 5 | Issue 12 | e15459Figure 4. cHes6-1 expression relative to expression of various genes involved in neurogenesis. (A-Oi) Double in situ hybridization shows
partial overlapping patterns and co-expression between cHes6-1 (green) and the following genes in spinal cord of E4 embryos: (A-Ci) cNeurog1, (D-Fi)
cNeurog2, (G-Ii) cNeuroM, (J-Li) cHes6-2 and (M-Oi) cDelta1 (red). (Ci), (Fi), (Ii), (Li), (Oi) are magnifications of the selected areas in (C), (F), (I), (L), (O),
respectively. Arrows indicate cells where genes are co-expressed. Horizontal lines in (F) and (Fi) separate the dorsal and ventral domains of the spinal
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(89% of electroporated embryos for cHes5-1, n=54) (Fig. 6D-H,
7B, and data not shown). Together, these results suggest that
cHes6-1 and cHes6-2 act at different steps of the neuronal
differentiation cascade and through different molecular mecha-
nisms.
Comparison of the two subgroups of HES6 proteins reveals that
a major structural difference is the size of the loop region in the
bHLH domain, with the HES6-1 subgroup including proteins
with shorter loops than HES6-2 proteins. The chick HES6-1
protein is particular in this aspect, as it contains the shortest loop (6
amino acids only) among all known vertebrate HES6 proteins
(Fig. 1B). This unique structural feature might underlie the
functional difference with cHES6-2 (which has a 10 amino acid
loop) detected in our assay. Actually, previous work on the mouse
counterpart of cHES6-1, mHES6, containing a 8 amino acid loop,
revealed that this protein is unable to bind DNA due to its short
loop, acting mainly through heterodimerization with other HES
proteins to inhibit their DNA binding-dependent transcriptional
repressor activity [8–11,13].
Two other structural features might contribute to the different
activities of cHES6 proteins. First, there is a specific serine residue
in cHES6-1 (position 175), conserved in the HES6-1 subgroup but
absent from HES6-2 proteins. Previous work on mHES6 has
shown that phosphorylation of this serine (at position 183 of
mHES6, within a putative PEST domain) by Casein Kinase 2
leads to proteolytic degradation of the mHES6-mHES1 hetero-
dimer, thereby contributing to the assayed neurogenic ability of
mHES6 [10]. The second feature is the presence of a conserved
lysine in HES6-2 (K59 in cHES6-2), conserved in all mouse HES
proteins with the exception of HES6, which contains an
asparagine residue in similar position. This lysine was shown to
be essential for the transcriptional repressive activity of mHES7,
using in vitro transcription assays [17], and its absence in mHES6
was suggested to contribute also for the inability to repress
transcription [17].
The short loop of cHES6-1, together with the presence of serine
175 and the absence of the lysine involved in transcriptional
repression, suggest that cHES6-1 does not bind DNA to repress
transcription, but rather interacts with other HES proteins to
inactivate them. By contrast, the longer loop of cHES6-2, the
absence of the serine, and the presence of lysine 59, all suggest that
cHES6-2 functions by direct DNA binding and transcriptional
repression. These observations raise the hypothesis that the
functional differences between cHES6-1 and cHES6-2 in our
assay arise from the different DNA-binding abilities of the two
proteins, with cHES6-2 being able to bind DNA and acting as a
transcriptional repressor of cHes5 genes, while cHES6-1 would
instead work by forming inactive heterodimers with HES5
proteins. These latter proteins are known to bind DNA and
repress their own transcription [16], so interference with their
activity by ectopic cHES6-1 expression might underlie the
observed up-regulation of cHes5 gene transcription.
To test this hypothesis, we engineered several variants of
cHES6-1 and cHES6-2 proteins (Fig. 7A) and evaluated their
activities in our electroporation assay, using the expression of
cHes5-1 as a read-out. The first variants to be tested involved the
substitution of lysine 59 of cHES6-2 by an arginine, as a similar
mutation in lysine 55 of mHES7 abolished its ability to repress
transcription [17]. Ectopic expression of cHES6-2K59R leads to
down-regulation of cHes5-1 (65% of electroporated embryos,
n=20), a phenotype similar to that obtained upon overexpression
of normal cHES6-2 protein (Fig. 7B). This result suggests that
lysine 59 of cHES6-2 is not important for the function of this
protein in our electroporation assay.
A variant of cHES6-1 was next generated where serine 175 is
replaced by an alanine. A similar mutation in mHES6 was shown
to impair the ability to target other HES binding partners for
degradation [10]. Ectopic expression of cHES6-1S175A leads
however to up-regulation of cHes5-1 (88% of electroporated
embryos, n=25), similar to overexpression of normal cHES6-1
(Fig. 7B), suggesting that serine 175 is not required for the activity
of cHES6-1 in our electroporation assay.
We then tested whether removal of the C-terminal WRPW
domain, which is known to be required for the transcriptional
repressor activity of HES proteins by recruiting the TLE co-
repressor, affects the function of chick HES6 proteins. We found
that ectopic expression of cHES6-2DWRPW leads to up-
regulation of cHes5-1 expression (54% of electroporated embryos,
n=13) (Fig. 7B), clearly contrasting with the activity of the non-
modified protein that normally represses cHes5-1 transcription
(49% of electroporated embryos, n=63) (Fig. 6I–J, 7B). In turn,
electroporation of cHES6-1DWRPW gives the same phenotype as
normal cHES6-1, causing up-regulation of cHes5-1 transcription
(95% of electroporated embryos, n=19) (Fig. 7B). Together, these
results show that the ability of cHES6-2 to repress transcription is
compromised by its incapacity to recruit the co-repressor TLE,
while cHES6-1 activity is not affected by the absence of the
WRPW motif, supporting our hypothesis that cHES6-1 is not
working as a DNA-bound transcriptional repressor in the
developing spinal cord.
To directly test whether DNA-binding is involved in the
differential activities of cHES6-1 and cHES6-2, we next
electroporated variants of these proteins where two arginines
from the C-terminus of the basic domain were replaced by
uncharged amino acids (AQ), an alteration that has been shown to
abolish the DNA-binding activity of several bHLH proteins
[11,13,38–44]. A similar mutant of mHES6 (HES6AQ), in
particular, was shown to lose the capacity to bind to Enhancer
of Split E (ESE) motifs [11,13], a specific type of E box recognized
by the Drosophila Enhancer of Split proteins [45] that can also be
recognized by mHES6 [11–13]. When cHES6-2AQ was electro-
porated in the embryonic neural tube, we observed an increase in
cHes5-1 transcription (77% of electroporated embryos, n=22),
again contrasting with the repressive activity of the normal
cHES6-2 protein. In turn, electroporation of cHES6-1AQ leads to
an increase in cHes5-1 expression (89% of electroporated embryos,
n=19), similar to what we observe when misexpressing unmod-
ified cHES6-1 (Fig. 7B).
In addition, we generated variants lacking both the WRPW
domain and the ability to bind DNA (RRRAQ mutations), which
we named cHES6-1AQDWRPW and cHES6-2AQDWRPW.
Their electroporation lead to similar results to those obtained
with the previous variants containing single modifications, causing
up-regulation of cHes5-1 transcription (75% of electroporated
embryos, n=12, for cHES6-1AQDWRPW and 78% of electro-
porated embryos, n=37, for cHES6-2AQDWRPW) (Fig. 7B).
cord. (P) Neuronal differentiation is a step-wise process: differentiating neural progenitors exit the IVZ (inner ventricular zone) and sequentially
activate neuronal differentiating genes during migration to the ML (mantle layer). cHes6-1 is transiently expressed in the OVZ (outer ventricular zone),
where it is co-expressed with various genes involved in neurogenesis.
doi:10.1371/journal.pone.0015459.g004
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that the two cHES6 proteins act through distinct molecular
mechanisms to modulate cHes5 transcription in our assay, with
cHES6-2 acting as a direct transcriptional repressor while cHES6-
1 acts by preventing cHES5 proteins from repressing transcription
of their own genes.
The proposed mechanism for cHES6-1 function is similar to
that described for mouse HES6, which does not require DNA
binding to inhibit HES1-mediated transcriptional repression, nor
for the induction of neurogenesis, acting instead by forming
inactive heterodimers with HES1 [8–11,13]. We therefore tested
mHES6 function in our electroporation assay and found that its
overexpression in chick embryos causes the same phenotype as
cHES6-1 (and opposite to cHES6-2), leading to similar up-
regulation of cHes5-1 expression (79% of electroporated embryos,
n=14) (Fig. 7B).
Figure 5. Regulation of cHes6-1 expression. (A-Ci) Double in situ hybridization for cHes6-1 (green) and cNotch1 (red), showing no co-expression
of the two genes in spinal cord of E4 embryos. (D-Li) cHes6-1 expression in the neural tube decreases after ectopic expression of NICD (D-Fi), and
increases after ectopic expression of CSLDN (G-Ii) and NEUROG2 (J-Li). (Ci), (Fi), (Ii), (Li) are magnifications of the selected areas in (C), (F), (I), (L),
respectively. Arrows pinpoint electroporated cells (GFP
+) with increased expression.
doi:10.1371/journal.pone.0015459.g005
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DNA binding nor the ability to recruit repressors for its function in
regulating cHes5 expression, suggesting that it normally acts by
directly sequestering the HES5 proteins. By contrast, DNA binding
ability and recruitment of TLE are absolutely essential for cHES6-2
to function as a transcriptional repressor of cHes5 genes.
Discussion
In this paper, we investigate a particular group of vertebrate Hes
genes, named Hes6, and identify two subgroups that are present in
zebrafish, medaka, Xenopus, and chick, which we named Hes6-1
and Hes6-2 (Fig. 1B). In contrast, only one Hes6 gene is present in
the mouse and human genomes, belonging to the Hes6-1
subgroup. The two chick Hes6 genes have been previously
identified [16] but only the function of cHes6-2 has been
investigated. We describe here the expression pattern and
functional characterization of cHes6-1 during early embryonic
development. Our results indicate that cHes6-1 shares a common
function during neurogenesis with cHes6-2, both contributing to
relieve differentiating neurons from Notch activity, although
through different molecular mechanisms.
cHes6-1 expression and regulation
Characterization of cHes6-1 expression pattern reveals that this
gene is active in all three germ layers, namely in the developing
nervous system, pancreatic progenitors and, asymmetrically, in the
left lateral mesoderm flanking the regressing node. This latter
expression suggests that cHes6-1 participates in the mechanisms
regulating the establishment of left-right asymmetry in the embryo.
The signalling molecule NODAL is known to play a central role in
these mechanisms, being asymmetrically expressed in the left
lateral plate mesoderm, where it induces the expression of its
downstream targets Nkx3.2 and Pitx2 to implement normal body
asymmetry (reviewed in [46]). Expression of Nodal occurs
sequentially in a wave-like fashion along the anterior-posterior
axis, and reaches the posterior end of the embryo at the 5-somite
stage, coinciding with the onset of expression of cHes6-1 in this
region. In addition, when Nodal expression in the posterior lateral
mesoderm is extinguished at late HH10, asymmetric expression of
cHes6-1 also starts to fade out (data not shown). This correlation
between the expression of Nodal and cHes6-1 suggests that this gene
is a downstream target of Nodal signalling in the left mesoderm
and might play a role in left-right asymmetry, in agreement with
Figure 6. cHES6 overexpression phenotypes. (A-Fi) Overexpression of cHES6-1 causes up-regulation of (A-Ci) cDelta1 and (D-Fi) cHes5-1. (Ci), (Fi)
are magnifications of the selected areas in (C) and (F), respectively. Arrows pinpoint electroporated cells (GFP
+) with increased expression. (G-J)
Whole-mount analysis of cHes5-1 expression in electroporated embryos shows that overexpression of cHES6-2 down-regulates cHes5-1 (I–J),
contrasting with the up-regulation caused by cHES6-1 overexpression (G–H).
doi:10.1371/journal.pone.0015459.g006
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Nodal signalling in Xenopus early gastrula embryos [47].
Notch signalling is also known to be an important player in L-R
asymmetry, at the time when this asymmetry is first established
around the Hensen’s node (reviewed in [46]). However, it is not
known if Notch also plays a role during the later stages when
cHes6-1 is expressed. Our results show that asymmetric expression
of cHes6-1 in the lateral mesoderm is dependent on Notch activity,
thus revealing that this signalling pathway continues to be active
during the process of generating L-R asymmetry in the embryo.
The transient and asymmetric expression of cHes6-1 raises the
question of which asymmetric structures arise from the lateral
mesoderm region expressing this gene. The position of cHes6-1-
expressing cells in the posterior mesoderm at HH10 suggests that
these cells will end up flanking somites 18 and forward, as
development proceeds. This region (between somites 18 and 21 of
stage HH14 embryos) has been previously fate-mapped to be the
main source of gonadal cells [48], which are known to develop
differently between the two sides of the chick [49–51]. It is thus
possible that the transient and asymmetric cHes6-1 expression in
the lateral mesoderm might contribute to gonad asymmetry in
chick development.
Early cHes6-1 expression also occurs in the ventral endoderm in
a salt-and-pepper pattern, starting at 6-7-somite stage. The
position of cHes6-1-expressing cells suggests that they are
pancreatic progenitors, although one of the first known markers
of these cells, Pdx1, only starts to be expressed at the 9-10-somite
stage [52]. However, pancreatic progenitors are known to have
been already specified at the 6-somite stage [52,53] and our results
suggests that cHes6-1 is an early marker for these cells, before Pdx1.
Figure 7. Phenotypical analysis of overexpressed cHES6 variants. (A) Schematic representation of various modified HES6 proteins
overexpressed in the chick neural tube. Altered functional domains are depicted in red. (B) Percentage of embryos showing up- or down-regulation
of cHes5-1 expression upon transfection with the different variants of cHES6-1 (black bars), cHES6-2 (grey) and mHES6 (white).
doi:10.1371/journal.pone.0015459.g007
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pancreatic cells and that its overexpression causes up-regulation of
Pdx1 expression [54].
We have found that cDelta1 and cHes6-2 are also expressed in
pancreatic progenitors at these early stages, suggesting that Notch
signalling plays a role in the early stages of pancreatic cell fate
specification. However, the finding that cHes6-1 expression is
negatively regulated by Notch activity in prospective pancreatic
cells indicates that this gene does not function as a Notch effector
in the process. Instead, as suggested by studies of pancreatic cell
differentiation at later stages [24], cHes6-1 is likely to be
downstream of NEUROG3, participating in the cascade of
bHLH proteins that regulate pancreatic differentiation. Since
Notch signalling leads to repression of Neurog3 expression during
pancreas development [22,24], this might explain the observed
down-regulation of cHes6-1 expression by Notch activity.
In the developing spinal cord, cHes6-1 is transiently expressed
during neuronal differentiation, in post-mitotic cells that co-
express proneural transcription factors. Our expression analyses
show that cHes6-1 and cHes6-2 are expressed at different steps of
the neuronal differentiation cascade, with cHes6-2 being expressed
before cDelta1, and cHes6-1 after, although co-expression of the
two cHes6 genes is still observed in some cells. We further show
that cHes6-1 expression is downstream of proneural transcription
factors and is not a direct target of Notch signalling, being instead
repressed by Notch activity, like in the prospective pancreas.
Overall, our results suggest the existence of three consecutive
stages in neuronal differentiation in the developing chick spinal
cord: proneural proteins and cHES6-2 act first during the decision
to commit to neurogenesis, followed by the expression of the
Notch ligand cDelta1 to inhibit neighbouring progenitors from
differentiating and, finally, by the expression of cHES6-1 and
NEUROM to regulate subsequent differentiation steps (Fig. 4P).
cHES6-1 and cHES6-2 have different mechanisms of
action
To investigate the functional role of cHES6-1 during neuro-
genesis, we used gain-of-function studies in the chick embryo, by
ectopically expressing the protein in the spinal cord neuroepithe-
lium. Our findings reveal that ectopic expression of cHES6-1
promotes commitment to neuronal differentiation, as suggested by
the cell-autonomous up-regulation of cDelta1 expression. However,
later markers for neuronal differentiation, like HuC/D and Tuj-1,
are not induced by cHes6-1 overexpression (data not shown),
suggesting that cells do not progress further into differentiation.
This is likely due to the fact that transcription of cHes5 genes is also
up-regulated by cHes6-1 expression, thereby repressing the
neuronal differentiation cascade. Furthermore, the high levels of
proneural gene expression required to trigger neuronal differen-
tiation are not yet reached in all neural progenitors at the
embryonic stages used for electroporation, a fact that might also
explain why these cells are not able to terminally differentiate
when electroporated with cHes6-1.
The results of cHes6-1 misexpression are in striking contrast to
the activities of the closely related gene cHes6-2 in the same assay,
which causes down-regulation of both cDelta1 and cHes5
expression. These functional differences are likely due to the
unique structural features of each cHES6 protein, in particular the
different sizes of the loop region within the bHLH domain, which
is known to constrain the DNA-binding capacity of HES proteins
[9]. Like its mouse counterpart mHES6, the chick HES6-1 protein
contains a short loop in the bHLH region and might be also
unable to bind DNA, functioning instead by sequestering anti-
neurogenic HES proteins in transcriptionally inactive complexes,
no longer able to repress their targets [8–11]. A conserved serine
residue might also contribute to this function, as shown for
mHES6, where it helps to target the mHES6/mHES1 heterodi-
mer for degradation, after being phosphorylated [10]. In contrast,
this serine is absent in cHES6-2, which contains a longer loop and
might therefore function as a DNA-bound transcriptional
repressor.
To test these hypotheses, we generated several variants of the
two cHES6 proteins that predictably affect their DNA-binding
capacity and/or their ability to repress transcription, and used
these variants in the chick electroporation assay. Our results show
that variants of cHES6-2 lacking the DNA binding ability, and/or
the ability to recruit the co-repressor TLE, lose the capacity to
repress cHes5-1 transcription, implying that cHES6-2 works
normally as a DNA-bound transcriptional repressor. In contrast,
similar variants of cHES6-1, where the ability to bind DNA and/
or to recruit co-repressors is missing, are still able to up-regulate
cHes5-1 transcription, like normal cHES6-1, showing that this
protein does not require DNA binding nor transcriptional
repression activity to function. This is further supported by our
finding that overexpression of mHES6, a known protein titrator
that does not require DNA binding nor the WRPW domain for its
neurogenic activity [8–11], causes also up-regulation of cHes5-1
transcription, like cHES6-1. However, the conserved serine
residue in cHES6-1 is not necessary for its capacity to up-regulate
cHes5 expression, suggesting that phosphorylation and proteolytic
degradation of cHES6-1/cHES5 heterodimers is not an absolute
requirement for HES6-1 activity. Although a similarly mutated
form of mHES6 (mHES6S183A) revealed no pro-neurogenic
activity in a different assay using in vitro culture of cortical
progenitors, proteolytic degradation of HES1 could still be
detected in the presence of mHES6S183A [10]. In our assay, we
didn’t measure the neurogenic activity of cHES6-1 and the target
is a different anti-neurogenic HES protein (HES5), so it is likely
that serine phosphorylation of cHES6-1 could still be important in
a different context where heterodimer formation with HES1 is the
main mechanism to promote neurogenesis.
Together, our results support the hypothesis that, like its mouse
counterpart mHES6 [9–11,13], cHES6-1 works by binding to
other HES proteins to inhibit their transcriptional repressive
activity. In our assay, where most of the electroporated cells are
cHes5-expressing neural progenitors, the ectopic expression of
cHES6-1 (or mHES6) would prevent cHES5 proteins from
repressing transcription of their own genes, breaking this negative
feedback loop and causing an increase in cHes5 transcription.
The related cHES6-2 protein, however, requires the presence of
the WRPW domain and an intact DNA-binding region to
effectively repress cHes5 transcription, strongly suggesting that
this member of the HES6 family works as a classical DNA-bound
transcriptional repressor. Thus, unlike the mouse, which contains
a single HES6 gene, encoding a protein that works mainly by
interfering with the anti-neurogenic activity of other HES proteins,
the chick embryo contains two clustered HES6 genes that function
through different but complementary mechanisms to regulate
neuronal differentiation.
What are the targets of cHES6-1?
During the normal process of neurogenesis, we have shown that
cHes6-1 is expressed in differentiating neurons, which normally do
not express cNotch1 or any cHes5 gene. However, it is possible that
cHES5 proteins perdure in cells committing to differentiation, even
if their mRNAs cannot be detected anymore, and cHES6-1 would
ensure that any remaining cHES5 activity is blocked. Another
possibletargetofcHES6-1iscHES6-2,astheencodingmRNAscan
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Li). We have shown previously that cHES6-2 helps to release the
differentiating neuron from Notch signalling, although its activity in
the absence of proneural proteins could also lead to a block in
neurogenesis [16]. It is therefore important to inhibit cHES6-2 for
neuronal differentiation to proceed and this function might be
accomplished by cHES6-1, which is expressed later than cHES6-2
in differentiating neurons (Fig. 4J-Li). We thus suggest that the two
cHes6 genes are part of a mechanism that functions to ensure that
Notch signalling is completely turned off when neuroepithelial cells
enterdifferentiation (Fig.8).Duringthis process,cHes6-2acts firstas
a transcriptional repressor of the progenitor program by repressing
transcription of the cHes5 genes encoding Notch effectors. This
might lead to a major increase in proneural gene expression which
reinforces cHes6-2 transcription and activates cHes6-1. Finally,
cHES6-2 activity is turned off by the activity of cHES6-1 and also
because it represses transcription of its own gene [16]. Together, the
two cHES6 proteins progressively and effectively shut down the
Notch-mediated progenitor program, making sure that neuronal
differentiation can proceed.
Materials and Methods
Embryo electroporation
For NICD, CSL and NEUROG2 expressing plasmids, super-
coiled DNA was injected into neural tubes of chicken embryos
staged HH11-HH13 or HH16-HH17 at a concentration of 2 mg/
ml in PBS and fast green was used for contrast. Platinum electrodes
(Nepagene CUY613P5), distanced 4 mm apart, were placed
parallel to the neural tube under the embryo. Using an Electro
Square Porator
TM ECM830 (BTX), we applied 4 pulses of 35 V
for 50 ms. Embryos were incubated for 16 h or 24 h and then
harvested.
For each construct, a minimum of 4 electroporated embryos
were analysed by in situ hybridization and immunofluorescence.
The results obtained after 16 h or 24 h were identical.
For the various HES6 plasmids, super-coiled DNA was injected
into neural tubes of chicken embryos staged HH8-HH11 at a
concentration of 1 mg/ml. Gold plated electrodes (BTX Genetrode
512), distanced 4 mm apart, were placed parallel to the neural
tube on the top of the embryo. Using an Electro Square
Porator
TM ECM830 (BTX), we applied 4 pulses of 25 V for
50 ms. Embryos were incubated for 6 h and then harvested.
Plasmids
The expression plasmids encoding NICD, CSLDN, NEUROG2
and cHES6-2 have been already described [16]. Plasmid constructs
to express the various HES6 proteins were generated in pCIG [55].
In all expression plasmids, IRES:GFP is present to allow
identification of electroporated cells. All clones were screened for
the correct orientation of the insert and were checked by
sequencing. Primers and cloning details are available upon request.
Figure 8. Model of cHES6-1 and cHES6-2 function during neurogenesis. During neuronal differentiation in the developing spinal cord,
cHES6-1 and cHES6-2 act sequentially to relieve the cell from Notch signalling: cHES6-2 acts first to repress the transcription of cHes5 genes and
cHES6-1 subsequently sequesters and inactivates cHES5 and cHES6-2 proteins.
doi:10.1371/journal.pone.0015459.g008
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To chemically inhibit Notch activity in ovo, 100 ml of the c-
secretase inhibitor LY411575, at 10 mM in PBS, were injected
under 3–8 somite staged embryos, in three independent
experiments. These embryos were harvested 7 h later. Control
was done with similar injections of PBS alone (17 embryos for the
asymmetry study, 23 for the pancreatic progenitors and 23 for the
neural tube). After 7 h of treatment, control embryos had an
average increase of 5 somites, as expected. In contrast, LY411575-
treated embryos only had an average increase of 3 somites. This
significant difference in the rate of somite formation between
control and LY411575 treated embryos (t-test; p-value,0.001),
suggests that the drug was effective in inhibiting Notch signalling
during somitogenesis.
In situ hybridization and immunofluorescence
Chicken embryos were collected and fixed in 4% paraformal-
dehyde in PBS overnight at 4uC. Whole-mount in situ hybridiza-
tions were done as described [37], with modifications. For
hybridization on cryostat sections, fixed embryos were cryopro-
tected in 30% sucrose in PBS, embedded in a solution containing
7.5% gelatine and 15% sucrose in PBS, and cryosectioned
(12 mm). Hybridization on cryostat sections was done as previously
described [56], with modifications. Double in situ hybridization on
cryostat sections was done with Digoxigenin (Dig)- and Fluorescein
(Fluo)-labelled RNA probes. The Dig-labelled probe was first
detected with AP-conjugated anti-DIG antibody (1:2000, Roche)
and developed with Fast-Red substract (Roche). After washing in
PBS, sections were blocked and incubated with HRP-conjugated
anti-Fluo antibody (1:1000, Roche), followed by FITC-Tyramide
amplification, as recommended by the manufacturer (TSA
TM-Plus
Fluorescein System Kit, Perkin-Elmer).
For the analysis of HES6 electroporations in the neural tube,
cDelta1 and cHes5-1 riboprobes have been synthesized from
specific PCR fragments, to avoid any plasmid regions in the probes
and eliminate regions of putative cross reactivity between the
probes and transgenes.
Electroporated cells were visualized after in situ hybridization by
immunohistochemistry using a rabbit polyclonal antibody against
GFP (1:500, AbCam). For BrdU treatment, 100 mL (12.5 mg/mL)
were dropped onto E4 chick embryos, which were harvested and
fixed 30 minutes later. Antigen retrieval for BrdU-treated embryos
was done using HCl 2N for 30 min at 37uC. Primary antibodies
used were mouse anti-BrdU (1:1000, Sigma) and mouse anti-Tuj-1
(1:500, Covance). Detailed protocols are available upon request.
Photos were taken using the stereoscope LeicaZ6APO with a
DFC490 camera attached, fluorescent microscopes Leica DMR or
Leica DM5000B with cameras DC350F or DC500 attached, and
the confocal Carl Zeiss 510 Meta.
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